Results · Jul-Sep 2025
Fredun Pharmaceuticals Q2 FY26 results
Sales 20%+, profit 30%+Growth band: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales were ₹144 crore & net profit ₹9.4 crore. The same quarter last year is not in our data, so there is no comparison yet.
Against Apr-Jun 2025: sales +20%, net profit +39%.
Get Fredun Pharmaceuticals' next results & call in your inbox, the day they're filed.
Free. One short email on the days it files or its shares make a big move, nothing on other days. Unsubscribe in one click.
The last 6 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.